Encompass Health’s (NASDAQ: EHC) hospice segment has proven resilient to pandemic-related headwinds compared to the company’s other business lines. Hospice saw revenue and census growth during the third quarter of 2020 even as the company’s home health operations saw some declines due to reduced referrals and fallout from the patient-driven groupings model (PDGM). The company is poised for further hospice growth with acquisitions in its pipeline for the fourth quarter and into 2021, as well as plans for de novo activity.
Read the full article: Encompass Health Hospice Segment Stands up to COVID-19 Headwinds //
Source: https://hospicenews.com/2020/10/29/encompass-health-hospice-segment-stands-up-to-covid-19-headwinds